HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation.

Abstract
Dendritic cells (DCs) sense the microenvironment through several types of receptors recognizing pathogen-associated molecular patterns. In particular, C-type lectins, expressed by distinct subsets of DCs, recognize and internalize specific carbohydrate antigen in a Ca(2+) -dependent manner. Targeting of these receptors is becoming an efficient strategy of delivering antigens in DC-based anticancer immunotherapy. Here we investigated the role of the macrophage galactose type C-lectin receptor (MGL), expressed by immature DCs (iDCs), as a molecular target for α-N-acetylgalactosamine (GalNAc or Tn)-carrying tumor-associated antigens to improve DC performance. MGL expressed by ex vivo-generated iDCs from healthy donors was engaged by a 60-mer MUC1(9Tn) -glycopeptide as a Tn-carrying tumor-associated antigen, and an anti-MGL antibody, as a specific MGL binder. We demonstrated that MGL engagement induced homotrimers and homodimers, triggering the phosphorylation of extracellular signal-regulated kinase 1,2 (ERK1,2) and nuclear factor-κB activation. Analysis of DC phenotype and function demonstrated that MGL engagement improved DC performance as antigen-presenting cells, promoting the upregulation of maturation markers, a decrease in phagocytosis, an enhancement of motility, and most importantly an increase in antigen-specific CD8(+) T-cell activation. These results demonstrate that the targeting of MGL receptor on human DCs has an adjuvant effect and that this strategy can be used to design novel anticancer vaccines.
AuthorsChiara Napoletano, Ilaria G Zizzari, Aurelia Rughetti, Hassan Rahimi, Tatsuro Irimura, Henrik Clausen, Hans H Wandall, Francesca Belleudi, Filippo Bellati, Luca Pierelli, Luigi Frati, Marianna Nuti
JournalEuropean journal of immunology (Eur J Immunol) Vol. 42 Issue 4 Pg. 936-45 (Apr 2012) ISSN: 1521-4141 [Electronic] Germany
PMID22531918 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Chemical References
  • Antigens, Neoplasm
  • Cancer Vaccines
  • Lectins, C-Type
  • MGL lectin, human
  • MUC1 protein, human
  • Mucin-1
  • NF-kappa B
  • MAPK1 protein, human
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Calcium
  • Acetylglucosamine
Topics
  • Acetylglucosamine (immunology, metabolism)
  • Antigens, Neoplasm (immunology)
  • CD8-Positive T-Lymphocytes (immunology, metabolism)
  • Calcium (immunology, metabolism)
  • Cancer Vaccines (immunology)
  • Cells, Cultured
  • Dendritic Cells (cytology, immunology, metabolism)
  • Humans
  • Lectins, C-Type (immunology, metabolism)
  • Lymphocyte Activation (physiology)
  • MAP Kinase Signaling System (immunology)
  • Mitogen-Activated Protein Kinase 1 (immunology, metabolism)
  • Mitogen-Activated Protein Kinase 3 (immunology, metabolism)
  • Mucin-1 (immunology, metabolism)
  • NF-kappa B (immunology, metabolism)
  • Phosphorylation (immunology)
  • Up-Regulation (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: